Cancer patients who are given the oral antibiotic vancomycin following stem cell transplants have greatly reduced rates of Clostridioides difficile infections, researchers at Fox Chase Cancer Center in Philadelphia found.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
